Connor, Clark & Lunn Investment Management (CC&L)
PRAH

Connor, Clark & Lunn Investment Management (CC&L)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,506
Closed -$291K – 1231
2020
Q1 		$291K Buy
+3,506
New +$342K ﹤0.01% 807

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PRAH Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 3,506 shares — an estimated $291K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PRAH in Q1 2020 and held it in 1 quarter. The position peaked at $291K in Q1 2020. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 3,506 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $291K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PRA Health Sciences, Inc. in Q1 2020 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s PRA Health Sciences, Inc. position peaked at $291K in Q1 2020.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.